Vivo Bio Tech Ltd receives GLP compliance from NGCMA

Vivo Bio Tech Limited has received the Certificate of Good Laboratory Practice (GLP) Compliance from the National Good Laboratory Practice (GLP) Compliance Monitoring Authority (NGCMA), Department of Science & Technology, Government of India.

The GLP certification specifically covers a wide range of non-clinical safety and regulatory studies, with includes the following critical and high-value study areas in addition to the other existing areas(s) of expertise;

- Toxicity Studies in Dogs, including repeated dose and specialized toxicological evaluations;

- Carcinogenicity Studies, supporting long-term safety assessment and global regulatory submissions;

- Eye Irritation / Serious Eye Damage Studies, including in vitro models, aligned with international regulatory recommendation to replace animal models.

The receipt of GLP accreditation for dog studies, carcinogenicity studies and in vitro eye studies significantly enhances the Company's capabilities to conduct globally acceptable non-clinical safety studies across multiple product lines and strengthens its credibility and positioning as a comprehensive GLP-compliant research test facility supporting international regulatory filings as a part of product registration mandate.

Shares of VIVO BIO TECH LTD. was last trading in BSE at Rs. 31.32 as compared to the previous close of Rs. 31.62. The total number of shares traded during the day was 13462 in over 105 trades.

The stock hit an intraday high of Rs. 32.97 and intraday low of 31.01. The net turnover during the day was Rs. 421762.00.

Source : Equity Bulls

Keywords

VIVOBIOTECH INE380K01017 Biotechnology GLPCompliance NGCMA